Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis
Ventriculitis or post-neurosurgical meningitis or healthcare-associated ventriculitis and
meningitis (VM) is a severe infection that complicates central nervous system operations or …
meningitis (VM) is a severe infection that complicates central nervous system operations or …
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with …
Introduction The choice of best therapeutic strategy for difficult-to-treat resistance (DTR)
Gram-negative infections currently represents an unmet clinical need. Areas covered This …
Gram-negative infections currently represents an unmet clinical need. Areas covered This …
[HTML][HTML] The blood–brain barrier and pharmacokinetic/pharmacodynamic optimization of antibiotics for the treatment of central nervous system infections in adults
N Haddad, M Carr, S Balian, J Lannin, Y Kim, C Toth… - Antibiotics, 2022 - mdpi.com
Bacterial central nervous system (CNS) infections are serious and carry significant morbidity
and mortality. They encompass many syndromes, the most common being meningitis, which …
and mortality. They encompass many syndromes, the most common being meningitis, which …
[HTML][HTML] Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections
Although available data are still limited, real-world evidence regarding mainly ceftolozane-
tazobactam and ceftazidime-avibactam could support the administration of novel beta …
tazobactam and ceftazidime-avibactam could support the administration of novel beta …
Extended and continuous infusion of novel protected β-lactam antibiotics: a narrative review
Consolidated data from pharmacokinetic and pharmacodynamic studies support the
administration of β-lactam antibiotics in prolonged infusion (ie, extended or continuous) to …
administration of β-lactam antibiotics in prolonged infusion (ie, extended or continuous) to …
[HTML][HTML] New antibiotics for the treatment of nosocomial central nervous system infections
R Nau, J Seele, H Eiffert - Antibiotics, 2024 - mdpi.com
Nosocomial central nervous system (CNS) infections with carbapenem-and colistin-resistant
Gram-negative and vancomycin-resistant Gram-positive bacteria are an increasing …
Gram-negative and vancomycin-resistant Gram-positive bacteria are an increasing …
Healthcare-associated central nervous system infections
M Ippolito, A Giarratano… - Current Opinion in …, 2022 - journals.lww.com
Clinicians should maintain a high index of suspicion for healthcare-associated central
nervous system infections in patients with specific risk factors (ie recent neurosurgery …
nervous system infections in patients with specific risk factors (ie recent neurosurgery …
Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant Pseudomonas aeruginosa …
EK McCreary, KE Byers, C Fernandes… - Open Forum …, 2020 - academic.oup.com
We report a case of multidrug-resistant Pseudomonas aeruginosa meningitis treated with
ceftolozane-tazobactam with concomitant therapeutic drug monitoring of plasma and …
ceftolozane-tazobactam with concomitant therapeutic drug monitoring of plasma and …
Antimicrobial use in central nervous system infections
F Ciummo, P Srinivas, J Biedny - Current Opinion in Infectious …, 2021 - journals.lww.com
Antimicrobial use in central nervous system infections : Current Opinion in Infectious Diseases
Antimicrobial use in central nervous system infections : Current Opinion in Infectious Diseases …
Antimicrobial use in central nervous system infections : Current Opinion in Infectious Diseases …
[HTML][HTML] Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry
GG Zhanel, R Dhami, M Baxter, J Kosar… - Journal of Global …, 2021 - Elsevier
Objectives Ceftolozane/tazobactam is a cephalosporin/β-lactamase inhibitor combination
with activity against Gram-negative bacilli. Here we report the use of ceftolozane/tazobactam …
with activity against Gram-negative bacilli. Here we report the use of ceftolozane/tazobactam …